Enliven Therapeutics, Inc. (ELVN): Shares Outstanding
59.44M
As of 2025-12-31
73.25M
As of 2026-06-30
+155.4%
3-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 59.44M | +21.5% | 2026-03-03, Balance as of period end |
| 2024-12-31 | 48.94M | +18.5% | 2026-03-03, Balance as of period end |
| 2023-12-31 | 41.29M | n/m | 2025-03-13, Balance as of period end |
| 2022-12-31 | 3.57M | -86.4% | 2024-03-14, Balance as of period end |
| 2021-12-31 | 26.29M | n/c | 2023-02-10, Balance as of period end |
| 2020-12-31 | 17.55M | n/m | 2022-03-15, Balance as of period end |
| 2019-12-31 | 702.5K | n/a | 2021-03-05, Balance as of period end |